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Synergistic Antimicrobial Effects 
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Javier A. Garza-Cervantes1,2, Arturo Chávez-Reyes3, Elena C. Castillo4,5, Gerardo García-Rivas  4,5, 
Oscar Antonio Ortega-Rivera6, Eva Salinas6, Margarita Ortiz-Martínez  1, Sara Leticia  
Gómez-Flores1, Jorge A. Peña-Martínez1, Alan Pepi-Molina7, Mario T. Treviño-González8,  
Xristo Zarate1,2, María Elena Cantú-Cárdenas1,2, Carlos Enrique Escarcega-Gonzalez1,2 &  
J. Rubén Morones-Ramírez1,2
Due to the emergence of multi-drug resistant strains, development of novel antibiotics has become 
a critical issue. One promising approach is the use of transition metals, since they exhibit rapid and 
significant toxicity, at low concentrations, in prokaryotic cells. Nevertheless, one main drawback of 
transition metals is their toxicity in eukaryotic cells. Here, we show that the barriers to use them as 
therapeutic agents could be mitigated by combining them with silver. We demonstrate that synergism 
of combinatorial treatments (Silver/transition metals, including Zn, Co, Cd, Ni, and Cu) increases up 
to 8-fold their antimicrobial effect, when compared to their individual effects, against E. coli and B. 
subtilis. We find that most combinatorial treatments exhibit synergistic antimicrobial effects at low/
non-toxic concentrations to human keratinocyte cells, blast and melanoma rat cell lines. Moreover, we 
show that silver/(Cu, Ni, and Zn) increase prokaryotic cell permeability at sub-inhibitory concentrations, 
demonstrating this to be a possible mechanism of the synergistic behavior. Together, these results 
suggest that these combinatorial treatments will play an important role in the future development of 
antimicrobial agents and treatments against infections. In specific, the cytotoxicity experiments show 
that the combinations have great potential in the treatment of topical infections.
In the past three decades, global usage of antibiotics has become disproportionate, and, in the major-
ity of instances, unsuitable1. This has led to the emergence of multi-drug resistant strains. Highly resistant 
Gram-negative bacteria, such as P. aeruginosa, Acinetobacter, Klebsiella and Escherichia species, have become 
worldwide relevant pathogens2 and are part of the ESKAPE list which includes the most current deadly path-
ogens3. In addition, some Gram-positive bacteria, such as methicillin-resistant Staphylococcus aureus1, 4, 5, and 
vancomycin-resistant Streptococcus pneumonia4, are pathogens also very difficult to treat. The spreading of 
antibiotic-resistant strains embodies an issue in which international health institutions spend millions of dollars 
annually5. As a result, increasingly significant attention has been paid to the development of novel antibiotics; 
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particularly metallo-pharmaceuticals, which are compounds that involve metals due to their therapeutic action, 
and currently belong to a class of promising antimicrobial compounds aimed to overcome resistant strains6–13.
Transition metal species, and remarkably silver compounds, lie among the most studied 
metallo-pharmaceuticals14, 15. Silver compounds have been used as antimicrobial agents since ancient times. It 
has been reported that Greek and Roman civilizations used silver as a disinfectant for water and food, as well as 
a wound-healing enhancer. Moreover, silver species had been widely applied in traditional Chinese medicine6–10, 
and lately, as disinfectants for water, fruits, and vegetables in several Latin American countries16. Hereafter, during 
the last decade, several health supplies, such as textile materials17, 18, implants, catheters, and gauze pads7, 8, have 
made extensive use of silver species and engineered delivery systems involving silver derivatives as antimicrobial 
agents6, 7, 10, 16. Recently, these antimicrobial developments have been focused to combat multi-drug resistant 
bacteria19. Nonetheless, silver is not the only transition metal widely used as an antimicrobial agent; zinc20, 21 and 
copper22 species are known to also exhibit antimicrobial effects. More interestingly, these metals are also consid-
ered as essential metals since they have been found to play key roles in many cellular processes23. However, even 
essential metals, when present in relatively high concentrations, become harmful24–27.
In bacteria, metal ions can inhibit growth completely at mM nominal concentrations28. In different E. coli 
strains this effect has been observed at >1 mM of total Co, and for sulfur-oxidizing bacteria isolated from con-
crete, complete growth inhibition can be observed at 5 mM Ni29. In addition, ROS stress responses have been 
observed at lower concentrations when using CuO nanoparticles with an E. coli biosensor at 0.1 mM Cu30. 
However, it is a well-documented fact that one of the main limitations in using transition metals as therapeutic 
agents is their toxicity to eukaryotic cells. The cytotoxicity of transition metals has been reported in the literature 
for human gingival fibroblast (HGF)31, TC50s of 78.7, 344, 705.8 and 872.9 µM, for Cd, Cu, Co, Ni respectively, and 
for HeLa cells32 the TC50 of Zn has been reported to be 600 µM.
To overcome the cytotoxicity drawbacks of using transition metals as antimicrobial agents, it has been sug-
gested that the overall minimum inhibitory concentration can be lowered by the formulation of proper combina-
tions of metals, resulting in effective therapies under the toxicity threshold10, 33. In this work, we hypothesized that 
this approach was suitable for silver/transition metal combinations, and used Escherichia coli and Bacillus subtilis 
as the Gram-negative and Gram-positive models, respectively, to test the synergistic effect of these combinatorial 
treatments. Our results support the effectiveness of this approach. When combinatorial treatments, composed of 
transition metals (zinc, copper, nickel, or cadmium) and silver, are tested against E. coli and B. subtilis, the combi-
nations exhibit up to an 8-fold enhancement in their antimicrobial properties, compared to the individual treat-
ments. We analyzed the combined antimicrobial effects and found them to be synergistic against E. coli and B. 
subtilis. Furthermore, we show that the minimum inhibitory concentrations of the transition metals are lowered 
significantly. We assessed the cytotoxicity of the treatments and found low cytotoxic effects for most combinato-
rial silver-transition metal treatments in three different cell lines (blasts and melanoma rat cell lines and a human 
keratinocyte cell line). The latter as a representation of the major cell line type found in the epidermis, which is 
reported to be a promising screening tool for predicting irritant and toxic skin effects34.
Materials and Methods
Minimum Inhibitory Concentration. Minimum Inhibitory Concentrations (MICs) were assessed in 
96-well plates (Costar, Corning) based on a modified methodology reported by Andrews35 and NCCLS36. Stocks 
of transition metal salts, NiSO4·6H2O, CoCl2·6H2O, 3CdSO4·8H2O, CuSO4·5H2O, ZnSO4·7H2O, were prepared 
at final concentration of 100 mM using distilled water as the vehicle. A stock solution of 5 mM AgNO3 was also 
prepared under similar conditions. To perform the MIC tests, we added in the top well the necessary volume 
from our stocks to reach a 16 mM concentration of the transition metal within a final volume of 200 µL. Next, 
serial dilutions were performed by taking 100 µL from every next well into 100 µL of culture media and discarding 
the last 100 µL from the last dilution. This way, the tested concentrations ranged from 8 to 0.0156 mM for the 
transition metals after the bacteria inoculum is added. A similar procedure was performed with the silver stock, 
where the top well was prepared to achieve a final concentration of 3840 µM, after addition of the inoculum. The 
nominal concentrations of Ag ranged from 1920 to 3.75 µM.
To inoculate each test well in the MIC assay, an overnight culture (20 hours culture incubated at 
37 °C–150 rpm) for each strain (Escherichia coli, ATCC-11229, or Bacillus subtilis ATCC 23857) was diluted 1:250 
in fresh medium and incubated until a critical optical density (OD600 of 0.2 ± 0.02) was reached; adjusting with 
fresh medium if necessary in order to reach a cell concentration range between 107–108 cells/mL. Cell number was 
monitored by the plate-counting method measured by serial dilutions. From this, a 1:100 dilution was made with 
fresh medium in a 1.5 mL tube, then 100 µL of this dilution was added to each test well in order to achieve a final 
concentration of 105 cells/mL, following incubation at 37 °C–150 rpm.
After 20 h of incubation at 37 °C, the ODs of the control and the treated inoculum were measured. We next 
determined that the MIC for each of the transition metals corresponded to the concentration at which no sig-
nificant growth was observed (OD600 < 0.05). All tests, and their respective control samples, were performed in 
replicates of 3.
MIC determination through Checkerboard assays for the silver/transition metal combinations 
(STMCs). Checkerboard assays37, 38 were performed in 96-well polystyrene plates, in order to unveil the syn-
ergistic effects of silver and transition metals. The assays tested the MIC of each transition metal and the STMCs 
corresponding to 0, 0.5, 0.25, and 0.125 of their respective individual MIC (Supplementary Figure S1). The MIC 
fractions of silver were prepared along the abscissa axis of the plate and the transition metal MIC fractions were 
placed along the ordinate axis of the plate. Concentrated metal solutions were prepared in culture media, so that 
when added to the culture the needed volume of metal and inoculum MICs fractions was reached.
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Bacterial cultures were grown for 16 h at 37 °C and 150 rpm, from which a dilution (1:250) was pre-
pared in fresh Luria Bertani broth (LB) medium, and incubated until it reached a critical optical density 
(OD600 = 0.20 ± 0.02), adjusting with fresh medium if necessary. This allowed us to obtain a concentration range 
between 107–108 cells/mL. A 1:20 dilution of this culture was adjusted in LB medium, followed by the addition of 
20 µL (1:10) of the inoculum, this resulted in an estimated concentration of ~105 cells/mL within a final volume of 
200 µL. The 96-well plates were incubated at 37 °C and 150 rpm for 20 h. After incubation, the ODs of the control 
and the treated inoculums were measured, and the respective values were recorded. Each STMC, and their corre-
sponding control samples, were tested in triplicates per plate.
STMCs at lower concentrations were made to emulate an isobologram analysis39, 40 in 96-well plates. MIC 
fractions of 0.25, 0.125 and 0.062 of silver and each transition metal (M) nominal concentrations were combined 
to achieve final ratios of: 0.062:0, 0.062:0.25, 0.062:0.125, 0.062:0.062, 0.125:0.062, 0.25:0.062, 0:0.062 of Ag:M in a 
final volume of 200 µL, including the bacteria inoculum. These combinations were diluted 2-fold and 100 µL were 
transferred each time after a thorough mixing and discarding the last 100 µL from the 5th dilution.
The inoculation of these wells was performed using the same procedure described in the MIC section. The 
96-well plates were incubated at 37 °C and 150 rpm for 20 h. After incubation, the ODs of the control and the 
treated inoculums were measured, and the respective values were recorded. Each STMC additional dilutions, and 
their corresponding control samples, were tested in triplicates.
Antibacterial effect of STMCs. One STMC per transition metal used was selected to assess its bactericidal 
activity at 1 h. The antimicrobial effect was tested in an overnight culture of E. coli ATCC 11229 that was diluted 
(1:250) in 250 mL of LB medium, followed by incubation at 37 °C-150 rpm until it reached exponential phase at a 
critical optical density (OD600 = 0.10–0.20). From this medium, 25 mL were transferred to 250 mL flasks, with the 
addition of their corresponding amount of STMC solution, and incubated at 37 °C and 150 rpm for 1 h. This time 
point was chosen in order to observe if there was a short-time exposure bactericidal effect. After incubation CFU/
mL were determined through the drop-count method. 10-fold diluted aliquots were obtained and, three 10 µL 
drops of each of the diluted samples were placed on LB agar plates. The plates were incubated at 37 °C during 24 h 
and at that time the viable bacterial colonies were counted. All tests, and their respective control samples, were 
performed in replicates of three.
Flow cytometry analysis. STMCs were prepared as described in the checkerboard methodology. The bac-
teria inoculum was incubated at 37 °C and 150 rpm for 20 h. After the incubation time, the bacteria were chilled 
on ice until they were analyzed. Flow cytometry with a propidium iodide dye was used to detect differences in 
membrane permeability10. A double-stain procedure with two fluorescent nucleic acid stains was followed as 
previously described41. Briefly, 106 bacteria were directly labeled and incubated (15 min, dark, room tempera-
ture) with propidium iodide 4 μg (PI, Sigma Aldrich, St. Louis, MO., USA) and SyBR-G 1X (Life Technologies, 
Carlsbad, CA., USA) in 250 μL PBS. For calibration purposes a sample of each bacteria was heated for 10 min at 
96 °C as a positive control. Analysis was performed in a BD FACS Canto II cytometer (BD, San Jose, CA., USA) 
configured with channel PerCP (670 LP nm band-pass filter) and FITC (530/30 nm band-pass filter) for PI and 
SyBR-G fluorescence acquisition, respectively. A total of 10,000 events per sample were collected at low flow rate. 
Signals were collected in a logarithmic scale in FSC and SSC and bacteria were double discriminated on green 
(live) and red (dead-permeable) fluorescence; double negative signals (debris) were also evaluated. Data were 
analyzed with the FlowJo software v.8.8.6 (Tree Star, Inc., Ashland, OR., USA) and the experiment was inde-
pendently replicated three times.
Cytotoxicity assay in mammalian cells. HaCaT cells, a spontaneously transformed human keratinocyte 
cell line, (kindly provided by Dr. Pablo Ortiz, CIBO, Mexico) were cultured in DMEM medium supplemented 
(sDMEM) with 1 g/L glucose, 4 mM L-alanyl-glutamine, 10% heat-inactivated fetal bovine serum (FBS; Gibco, 
NY, US), 50 IU/penicillin and 50 μg/ml streptomycin (Sigma, Israel) at 37 °C and 5% CO2. To measure mitochon-
drial activity as a viability marker, the MTT assay was performed in triplicates, as described previously42 with little 
modifications. To expose the cultures to the individual metals and the STMC treatments, 96-well microplates were 
seeded with 4 × 104 cells in 100 μl of sDMEM and left to attach overnight. Next, the old medium was replaced 
with 200 μl of sDMEM previously formulated with the different concentrations of transition metals. 10% DMSO 
was used as a positive control and medium alone as the negative control. After a 24 h exposure, the medium was 
discarded and 100 μl of fresh MTT solution (0.5 mg/ml of MTT in DMEM medium without FBS) was added to 
the cells and they were incubated for 4 h at 37 °C and 5% CO2. The MTT solution was substituted with 100 μl of 
Isopropanol-0.04 N HCl, in order to dissolve the formazan crystals and the optical density (OD595nm) (655 nm in 
the reference) was measured in an iMark microplate reader (Bio-Rad, Tokyo, Japan). Viability was calculated as 
the ratio of the mean between the OD595nm of the treated groups and the OD595nm of the negative control.
H9c2 cells (Rat cardiomyoblast, CRL-1446, ATCC, Manassas, VA, USA) were maintained at 37 °C in a 5% 
CO2 humid atmosphere in 25 cm2 culture flasks in DMEM media supplemented with 10% fetal bovine serum 
(FBS), penicillin (100 U/mL) and streptomycin (100 µg/mL). Cytotoxicity of transition metals was analyzed 
on H9c2 cells. Briefly, once H9c2 cells reached 70–80% confluence in the 25 cm2 flasks, cells were plated into 
96 wells trays at a density of 2 × 103 cells per well in 100 µL medium. Mouse skin melanocytes (B16F10 cells, 
CRL-6475, ATCC, Manassas, VA) were maintained at the same culture conditions described above, except that 
they were in a DMEM/F12 culture medium supplemented with 10% FBS and 1X antibiotic-antimitotic (all from 
ThermoFisher Scientific, Waltham, MA) and plated into 96 wells plates at a cell density of 5 × 103 cells per well 
in 100 µL of medium. For these cell lines, twenty-four hours after they were plated, the different treatments were 
added and then the treated cells were incubated for 48 h. Cytotoxicity was assessed, for both cell lines, by the 
AlamarBlue® assay (Invitrogen, Eugene, OR) according to the manufacturer instructions. The half maximal 
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inhibitory concentration (IC50) was determined using the software Origin (Northampton, MA), as previously 
reported43. All experiments, and their respective controls, were performed in triplicates.
Data analysis and Calculations of Free Ions in Solution. To estimate the significance of the observed 
differences between the treatments employed, all collected data was subjected to an analysis of variance (ANOVA) 
and Fisher’s least significant difference (LSD) tests, using Microsoft Excel 2013.
The interaction of silver with transition metals was analyzed using the Bliss independence model described by 
Hegreness et al.4, which states that the interaction can be considered as synergistic when the combined effect of 
the antimicrobial agents is greater than the predicted effect of its individual components. Therefore, the S value; 
the difference between the predicted value of individual components x and y (fx0 and f0y, respectively) and the 



























where: fx0 = treatment with Ag, f0y = treatment with the transition metal, fxy = treatment Ag + metal, f00 = growth 
control of a culture that has not been treated with the transition metals. The value of S describes the interaction 
between combinatorial treatments as follows: S > 0 Synergistic; S = 0 Additive; S < 0 Antagonistic.
Speciation for metals and STMCs was performed using the Visual MINTEQ 3.1 program designed and devel-
oped by Jon Petter Gustafsson at KTH in Sweden44. Metal species were calculated using medium formulations as 
reported by manufacturers (BD, ThermoFisher Scientific, Sigma-Aldrich) at 37 °C, and pH of 6.8 and 7.0 for LB 
and DMEM mediums, respectively.
Results and Discussion
Microbial Toxicity of Transition Metals in Prokaryotic Cells. Since the times of the first human 
civilizations, society has taken advantage of the antimicrobial properties exhibited by different metals22, 45, 46. 
Nowadays, there is a wide variety of compounds and materials that exhibit antimicrobial activity due to their 
transition metal content, such as Ag, Zn and Cu21. We here hypothesize that treatments involving silver salts 
and transition metal combinations (STMCs) will exhibit synergistic antimicrobial effects, when compared to the 
effect of the individual compounds. To evaluate the properties of the different STMCs, we analyzed the syner-
gistic effects of antimicrobial activity in E. coli (Gram-negative microorganism) and B. subtilis (Gram-positive 
microorganism).
We first tested Zn, Cd, Ni, Co, Cu and Ag at different concentrations to determine their individual MIC values. 
The summary of the observed MIC values is displayed in Table 1. Most of the metals tested in E. coli, Zn, Cd, Ni, 
Co, and Cu, Ni, Co and those in the assays for B. subtilis have MICs between 1 and 2 mM. Only Cu, with an MIC 
of 4 mM in E. coli assays, and Ag with an MIC of 60 µM for both microorganisms, were found apart from the 
range previously mentioned. All of these MICs correlate with those found in the literature10, 47, 48. Moreover, the 
available free metal ions in the medium may vary due to its composition; therefore, total free ions were calculated 
and are reported in parenthesis in Table 1 and also in Supplementary Tables S1 and S2. As can be observed in 
Tables 1, S1 and S2, the percentage of the total metal available as free ions varies depending on the metal and its 
concentration.
Synergistic effect of silver/transition metal STMCs. We tested combinations of Ag with different tran-
sition metals (Cu, Co, Zn, Ni and Cd) via a checkerboard assay, a widely used methodology to test synergistic 
effects between antimicrobial agents38, 49–51. The inhibitory effect of the different transition metal combinations 
with silver against E. coli is shown in Fig. 1. It can be observed that a reduction to 0.25 of the MIC of silver is 
achieved when combined with Zn, Cd, Ni, and Cu. Moreover, a reduction to 0.5 of the MIC of each of the transi-
tion metals is shown, respective to the values when tested alone (Fig. 1A–D). Cd, Ni, and Cu were able to enhance 
the antimicrobial activity of silver at both: 0.5 and 0.25 of their individual MICs (Fig. 1A,B,D), whereas similar 
behavior was observed in the case of Zn, when present at 0.5 of its MIC, albeit in a lower extent (Fig. 1C). All the 
STMCs, with inhibitory activities above 80%, exhibited statistically significant differences when compared to 
the treatments with individual transition-metal salts (p < 0.05). Only the STMCs made with Co were not able to 
increase the inhibitory effect of the silver MIC fractions.
Figure 2 shows that the transition metal that best enhanced the inhibitory activity of Ag against Bacillus sub-
tilis was Zn, since it decreased its MIC to 0.125 and 0.25 when combined with 0.5 of the MIC of Ag. For the rest 
Transition Metal
E. coli Nominal (Free 
ion)
B. subtilis Nominal 
(Free ion)
Ag 60 µM (22.8 nm) 60 µM (22.8 nm)
Zn 2 mM (980.1 µM) 0.25 mM (118.7 µM)
Cd 2 mM (229.3 µM) 0.015 mM (0.16 µM)
Ni 2 mM (531.6 µM) 2 mM (531.6 µM)
Cu 4 mM (163.9 µM) 2 mM (2.4 µM)
Co 1 mM (656.4 µM) 1 mM (656.4 µM)
Table 1. Nominal (Free Ion) Minimum Inhibitory Concentrations of Individual Transition Metals. MICs for 
each of the individual transition metals and Ag were determined under identical culture conditions.
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of the metals, when combining 0.5 MIC of each individual transition metal, the experiments show that >80% 
inhibition can be achieved with each of the fractional Ag MICs tested. For the case of Cu the data shows that at 0.5 
and 0.25 of the Cu MIC, the MICs of Ag can be decreased four and two-fold, respectively, to achieve >80% inhi-
bition in B. subtilis. Ni and Co at 0.5 MIC can enhance by two-fold the inhibitory effect of Ag. The calculated free 
ions of the STMCs tested in both bacteria are reported in Supplementary Tables S3 (E. coli) and S4 (B. subtilis).
The results described here have also been observed with different transition metals in the form of complexes 
against Gram-positive bacteria52 and fungi53, 54. In this work, we observed that four of the five metals used, when 
combined with silver, were able to increase the inhibitory effect of silver MIC fractions in E. coli. Only Co did 
not show this effect significantly. Similarly, in the assays made with B. subtilis, four of the five metals were able to 
increase the effects of Ag. Only for the case of Cd we did not observe the phenotype. Previously, different reports 
have used transition metals (primarily in nanoparticle or polymeric systems) in combination with silver to take 
advantage of its inhibitory effects; such is the case of Cu55, Zn56 and Co57.
The nature of the interactions between the components of the STMCs, in virtue of their antimicrobial effect 
against E. coli, were assessed as a function of their individual and combined activities using the Bliss Mathematical 
Model represented in Equation 1. These results are displayed in Fig. 3 and they show that the overall response 
appears to be synergistic. Even in the samples with inhibitory activities below 80%, the effect was slightly higher 
than the individual counterparts (Fig. 3A–D). In the case of Ni and Cu, an antagonistic interaction with Ag can 
be observed (Fig. 3A,B), however, this behavior is not present when one of the concentrations of the components 
increases, particularly in Ni, which exhibits synergistic effects when the concentration of Ag is found at 0.5 of its 
MIC (Fig. 3A).
Figure 4 shows the interactions between components in the B. subtilis assays. The interaction between Ag-Ni 
can be classified as synergistic, especially in the combinations of 0.125, 0.25 and 0.5 MIC of Ni with a 0.25 MIC 
of Ag. However, we can see that in combinations with high concentrations of Ag the interaction is antagonistic, 
changing with the increase of Ni. In the same manner, at low concentrations of Ag and Cu the interactions are also 
antagonistic, but they switch to synergistic with combinations of 0.25 and 0.5 MIC of Ag with 0.5, 0.25 and 0.125 
MIC of Cu. The same synergistic effect can be observed with Ag-Zn at 0.25 and 0.5 MIC of Ag with 0.5, 0.25 and 
0.125 MIC of Zn. With Co the only combinations that can be classified as synergistic are 0.5 MIC of Ag with 0.5 
MIC of Co and 0.5 MIC of Ag with 0.25 and 0.5 of Co.
To explore a possible hormesis effect, exhibited in some biological systems where effects (such as growth) are 
accentuated in the presence of low concentrations of a compound58, we performed treatments at lower concen-
trations of the STMCs. The results demonstrated that no significant inhibitory or enhanced growth effects where 
Figure 1. Inhibitory Effect of the MIC dilutions of Ag potentiated by transition metals against E. coli. 
Inhibitory percentage by sub-inhibitory combinations of Ag-transition metals in Escherichia coli ATCC 11229. 
Experiments with combinatorial treatments of Ag with (A) Ni, (B) Cu, (C) Zn and (D) Cd. Each combinatorial 
treatment with inhibition >80% is significantly different to the effects of the individual treatments. Each 
checkerboard treatment was performed in triplicates.
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shown for most of the STMCs. Only for the case of Ag-Ni and Ag-Co a slight hormesis effect was observed in B. 
subtilis. (Supplementary Tables S5 and S6).
Even though there is a wide array of literature focused on combination of antimicrobial agents and their 
enhanced effects as a combined treatment, the nature of the interaction of the combined components has not 
been widely explored. Different works have reported conditions where both synergistic and antagonist effects 
have been observed between Ag-Cu, the interaction depends on the bacterial species treated59. In this work, it 
can be observed that for the case of Gram-negative E. coli, most of the STMCs showed strong synergistic effects. 
In Gram-positive B. subtilis, the same combinations, although exhibited synergistic behavior, most of them are 
closer to an additive behavior. As can be seen in Figs 3 and 4, most of the synergistic interactions are found at 
combinations between the higher MIC fractions, and as the MICs fractions decrease, the interactions shift to 
an antagonist nature. This effect, although stronger for our experiments with Gram-positive bacteria, was also 
observed in our assays with Gram-negative bacteria. A very similar behavior has been previously reported for 
combinations with Ag-Cu tested in L. pneumophila60. In other cases, as shown in Fig. 4, an STMC can exhibit syn-
ergistic behavior, but when the concentration of one of the components decreases the synergistic effects increases. 
A reason for this could be that, since some of the STMCs have similar cellular targets, when high concentrations 
are present one of the components could be acting in an overlapping target, but when lowering the concentration, 
both can exert its antimicrobial activity separately27.
Enhanced bactericidal activity of Ag in silver/transition metal STMCs. To determine the ability of 
each transition metal and the STMCs to kill both Gram-negative and Gram-positive bacteria, we studied their 
bactericidal effects by exposing exponentially growing bacteria to different treatments. Figure 5 provides a rep-
resentation of the bactericidal activity found for each STMC in E. coli. Evidently, Cd, Cu and Zn (Fig. 5B–D) were 
found to significantly enhance the bactericidal activity of Ag against viable E. coli in exponential phase (p < 0.5). 
In addition, the measured data demonstrates that the enhanced activity of silver reduces cell concentration (CFU/
mL) between 2 and 4-log, compared to the decrease associated with the individual Ag treatment. However, Ag-Ni 
combinatorial treatments exhibited activities resembling that of the individual Ag antimicrobial effect (Fig. 5A), 
even though Ni was found to enhance the inhibitory activity of Ag (Fig. 2A). The same assays were performed 
with B. subtilis and the inhibitory STMCs; however, the results show no significant enhanced bactericidal effect 
(Supplementary Figure S2A–D).
Flow cytometry analysis. The mechanism of antimicrobial synergy between silver and transition metals 
was explored by running cytometry assays using propidium iodide to determine changes in permeability. The 
Figure 2. Inhibitory Effect of the MIC dilutions of Ag potentiated by transition metals against Bacillus subtilis. 
Inhibitory percentage by sub-inhibitory combinations of Ag-transition metals in Bacillus subtilis ATCC 23857. 
Experiments with combinatorial treatments of Ag with (A) Ni, (B) Cu, (C) Zn and (D) Co. Each combinatorial 
treatment with inhibition >80% is significantly different to the effects of the individual treatments. Each 
checkerboard treatment was done in triplicates.
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Figure 3. Analysis of Ag-Transition Metal Interactions. Classification of the different interactions between 
Ag-transition metal in Escherichia coli ATCC 11229. The interactions of Ag with (A) Ni, (B) Cu, (C) Zn and (D) 
Cd, are classified as synergistic, additive or antagonistic, value >0, =0 and <0, respectively. Each checkerboard 
treatment was done in triplicates.
Figure 4. Analysis of Ag-Transition Metal Interactions. Classification of the different interaction between Ag-
transition metal in Bacillus subtilis ATCC 23857. The interactions of Ag with (A) Ni, (B) Cu, (C) Zn and (D) 
Co, are classified as synergistic, additive or antagonistic, value >0, =0 and <0, respectively. Each checkerboard 
treatment was done in triplicates.
www.nature.com/scientificreports/
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Ag-Cu, Ag-Ni and Ag-Zn STMCs were selected since they showed inhibitory effects in both, Gram-positive 
and Gram-negative bacteria. At high Ag concentrations (30 μM) with the different transition metals at 1 mM 
(Cu, Ni, or Zn), cell death (Supplementary Fig. S3A,D) and lysis was clearly observed for both microorganisms. 
These STMCs also showed a high percentage of debris (Supplementary Fig. S3C,F) and in addition, an increased 
permeability was noticed (Supplementary Fig. S3B,E). Lower doses at half the lethal dose concentrations (Ag 
15 μM) in combination with 0.5 mM (Cu, Ni, or Zn) show that across the range of concentrations, none or very 
slight cell death is observed for both E. coli (Fig. 6A) and B. subtilis (Fig. 6C). However, the permeability of the 
cells increases significantly between 20 to 50% for both microorganisms (Fig. 6B,D). Since bacterial membranes 
contain polymers with highly electronegative chemical groups, these can serve as sites for metal cation adsorp-
tion. Because of their ability to coordinate metals, it has been postulated that the membrane is the site at which 
some metals exert bactericidal toxicity. For Ag treatments, there are reports that show that Gram-negative and 
Gram-positive bacteria exhibit morphological changes, like the formation of a big cap between the cytoplasm 
membrane and the cell wall, causing serious damage on the latter61, as well as induction of OH· production10. 
Additional works have also shown that Zn, as ZnO nanoparticles, can cause disruption of membrane morphology 
and induce oxidative stress62 in both Gram positive and Gram negative bacteria, similar to the effects shown with 
Ag treatments. On the other hand, Ni, Cu and Cd have been reported to cause disruption of biological processes 
within the cell, causing DNA alterations63, and increased lipid peroxidation22, 64, 65. Therefore, our results show 
that one possible mechanism of synergy between the STMCs, in both B. subtilis and E. coli, could be an initial 
increase in permeability and damage of the cell wall followed by disruption of different internal cellular processes.
Toxicity Data for the Different Transition Metals. A data analysis was performed to compare the total 
MICs and the effective bactericidal total concentrations of the individual transition metal treatments with those 
concentrations of transition metals previously reported as toxic in the literature. Table 2 shows the different toxic 
concentrations of transition metals and their effects reported in the literature for rats/mice and humans. As can 
be seen, some of the total MICs used here are within or slightly higher than the range of doses reported as lethal 
to rats/mice. For the case of E. coli the total concentration MICs of Co, Cd and Ni at 1 mM (59 ppm), 2 mM 
(225 ppm) and 2 mM (117 ppm), respectively, meet the above criteria. Meanwhile with B. subtilis only MICs of Co 
Figure 5. Bactericidal Effect of Ag Potentiated by Transition Metals. Log change in CFUs/mL with respect 
to time zero, in Escherichia coli ATCC 11229 after 1 hour treatment with: LB (control), Ag, specific transition 
metal and their combination. As nominal concentrations: (A) Ag 30 µM, Ni 0.5 mM and the combination; (B) 
Ag 30 µM, Cd 1 mM and the combination; (C) Ag 15 µM, Cu 1 mM and 2 mM, and the respective combinations; 
(D) Ag 30 µM, Zn 0.5 mM and the combination. ***Corresponds to a p < 0.05, tested with an ANOVA, that 
there is a difference with respect to the control and each of the individual treatments. Error bars correspond to 
the standard deviation from experiments performed in triplicates.
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and Ni at 2 mM (118 ppm) and 2 mM (117 ppm), respectively, can be considered within the range of the reported 
non-lethal doses.
However, as previously described in this work, when testing the metals in combinations with Ag, the MICs 
were reduced by different fractions, depending on the metal and the microorganism. In E. coli, the total con-
centrations used for the combinations were Cu 1 mM (64 ppm), Zn 1 mM (65 ppm), Cd 0.5 mM (56 ppm) and 
Ni 0.5 mM (59 ppm). In B. subtilis these concentrations were Cu 0.5 mM (32 ppm), Zn 0.03 mM (16 ppm), Co 
0.25 mM (15 ppm) and Ni 1 mM (59 ppm). Interestingly, the final concentrations used for the combinatorial treat-
ments are all lower than those reported as lethal for mice and rats. However, these concentrations are still higher 
than those reported as harmful in human oral cases.
To explore the cytotoxic effects of the transition metals and STMCs tested in this work, we first performed via-
bility experiments in human keratinocytes (HaCat cells). Supplementary Figure S4 shows the viability for HaCat 
cells in culture treated with the transition metals used in this work, at the concentrations reported as the E. coli 
nominal metal MICs. Across the range of concentrations we observed no significant viability (p < 0.05). Most of 
the metals exhibited an average toxicity of 90%, except Ni with 55% at 24 h of treatment.
Toxicity experiments were performed in another cell line, H9c2 cells, to explore an additional toxicity assay. 
Figure 7A shows a calculated IC50 value of 3.12 µM for the treatment with individual Ag. This result indicates a 
strong cytotoxicity of the individual metal. Additional toxicity assays were performed, in H9c2 cells, for the rest 
of the transition metals, at the nominal concentrations at which they showed antibacterial activity (1 mM). As 
can be observed in Fig. 7B, Ni and Co did not produce important effects, showing only 15% and 38% cytotoxicity 
values, respectively. However, Cu and Zn showed about 60% cytotoxicity at the same concentration. Cd, on the 
other hand, showed to be moderately toxic with about 50% cytotoxicity. Additional concentrations were tested 
for each of the metals and, with exception of Cd, a typical dose-response effect was observed (Fig. 7C). IC50s were 
calculated and the results show that for all the metals, except Zn and Cd, values are higher (Table 2) than the 
respective MIC values reported in this work for the transition metals (Table 1). Ni showed to be the less toxic for 
H9c2 cells, as it needed about 16.5-fold concentration increase in order to reach its IC50. Co reaches its IC50 with 
a 20-fold concentration increase. Zn IC50 is similar to its MIC value. Due to the similar cytotoxicity of Cd at all 
tested concentrations, it was not possible to adjust a typical curve to calculate its IC50 value, but according to the 
trend observed, it is lower than 0.1 mM.
Even though the individual metals and STMCs showed cytotoxicity against some of the different cell lines, one 
explanation could be the difference in the concentrations of free ions available in the medium used in the exper-
iments to calculate MICs (LB), compared to the concentration of free ions in the medium used to calculate the 
IC50 cytotoxic dose (sDMEM and DMEM). Therefore, the free ion concentrations needed to be correlated in both 
Figure 6. Viability and cell permeability assay of B. subtilis and E. coli treated with STMCs. Nominal 
concentrations of Ag/Cu Ag/Ni and Ag/Zn (15 μM/0.5 mM) by 24 h (37 °C). (A) SyBR-G B. subtilis positive cells 
represented as a measure of % of viability; whereas (B) B. subtilis PI positive cells are represented as a measure 
of % of permeability. (C) SyBR-G E. coli positive cells represented as a measure of % of viability; whereas (D) 
E. coli PI positive cells are represented as a measure of % of permeability Values represent mean ± SD (n = 3 
experiments for each treatment). P values *P < 0.05 vs. Control, **P < 0.01 vs. Control.
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experiments to correctly determine the effect of the different metals and the STMCs. Supplementary Table S7 
shows the calculated free ion concentrations corresponding to the nominal concentrations for each of the dif-
ferent media used. As can be observed, some metals, at equivalent nominal concentrations, show differences in 
the calculated free ion concentrations for the different culture medium. Based on this data, the STMCs for three 
transition metals were adjusted to perform additional cytotoxicity assays at equivalent free ion concentrations. 
Table 3 shows the new nominal concentrations used. A comparative of the free ions calculated for these mediums 
is reported in Supplementary Table S7.
Experiments on HaCat cells involving 24 h treatments with transitions metals at the equivalent free metal ions 
concentrations were performed. It was observed that the percentage of viability significantly increased above 90% 
for all of the metals (p < 0.01) except for Co at 750 μM where the toxicity was maintained (44.00 ± 1.24%) (Fig. 8). 
The same phenotype was noticed for the STMCs, all of them showed viabilities above 90%, with the exception of 
the Ag-Co STMC, with 750 μM Co, which showed a viability of 60%, and the Ag-Cu STMC at the highest concen-
tration of 300 μM Cu, which showed a viability of 50% (Fig. 9). A positive cytotoxicity control treatment with 10% 
DMSO was used in both experiments, and a viability of 16.32 ± 3.54% was obtained.
As a complementary test to the MTT assay, the cells were evaluated qualitatively with an optical microscope 
(200X) (Figures S5 and S6). Compared to the control group, notable changes in the monolayer confluence and 
cell morphology, as well as an increase in the number of floating cells, were markedly seen in groups such as Co 
750 μM (Fig. S5F) and also in the positive control (10% DMSO) (Fig. S5B). These results correlate well with the 
MTT results. On the other hand, groups such as Ag 15μM-Co 750 μM (Fig. S6C) showed a lesser change in mon-
olayer confluence and cell morphology compared to the Co 750 μM treated group (Fig. S5F), but a considerable 
number of floating cells were observed as compared to control. This was also noted in the MTT assay, where 
viability of these groups decreased but it was not statistically significant. The rest of the treatments did not seem 
to suffer changes in the features assessed optically. In an interesting way, some of the groups that showed a higher 
viability than the control (p < 0.001) in the MTT assay, looked optically similar to the control group. Therefore, 
such increment can be related more to a higher metabolic activity than to a higher number of cells.
As well as with HaCat cells, STMCs at the adjusted free metal ion concentrations were performed in both 
H9c2 and B16F10 cells. Ag cytotoxicity on H9c2 cells is significantly inhibited when used in combination with 
Cu (Fig. 10B). When Ag concentration is 15 µM the cytotoxicity is about 50%, but when 80 µM of Cu is added, 




 Cu 300–794 LD50 66, 67
 Zn 337–1710 LD50 67, 68
 Co 42.4 LD50 69
 Cd 100–300 LD50 70
 Ni 39–46 LD50 71
Human (oral)
 Cu 0.091–6 Gastrointestinal1 66
 Zn 0.5–6.7 ↓Cortisol, ↑LDL, gastrointestinal 68
 Co 0.18–1 Gastrointestinal 69
 Cd 0.07 Gastrointestinal 70
 Ni 7.1–35.7 Gastrointestinal 71
Human (dermal)*
 Cu 2–5% as CuSO4 (20 000–50 000) Irritation 66, 67
 Zn 1–2.5% as ZnSO4 (10 000–25 000) May present irritation 67, 68
 Co 1% as CoCl2 (10 000) Contact allergy 69







 Cu 2 IC50 This work
 Zn 3 IC50 This work
 Co 20 IC50 This work
 Cd 0.1 IC50 This work
 Ni 33 IC50 This work
Table 2. Toxicity data of transition metals. 1Gastrointestinal effects may include nausea, vomiting, diarrhea, 
abdominal cramps. *Dermal exposures expressed the metals salt reported in each case.
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cells (Fig. 10B). Cytotoxic effects were also analyzed on melanocytes (B16F10 cells), to observe the effect at the 
same total concentrations as the experiments with HaCat and H9c2 cells. The results obtained can be compared 
to those observed in the highly sensitive H9c2 cell line. Ag alone was not found to be cytotoxic to melanocytes 
(Fig. 7A). In addition, Ag/Zn or Zn alone had not significant cytotoxic effects on B16F10 cells and the combina-
tions of the rest of the metals with Ag did not potentiate their toxicity (Fig. 10A). Taken together, these results 
suggest that one of the most promising combination is that of Ag with Cu since it shows potential to treat bacterial 
infections with limited cytotoxic effects on mammalian cells.
The differences in the Ag and STMCs cytotoxic concentrations observed between the different cell lines tested 
in this work could be explained by the nature of the cells. H9c2 cells are blasts, which normally are sensitive to a 
variety of insults and they are programmed to die to avoid passing mutations or damage to the progeny. On the 
Figure 7. Cytotoxicity effects of Ag and transition metals on H9c2 and B16F10 cells. (A) H9c2 and B16F10 
cells were treated with Ag at the indicated concentrations for 24 h and viability was determined. (B) Effect of 
transition metals on the viability of cells H9c2. Cells were treated with each transition metal at a concentration 
of 1 mM for 48 h and viability was determined. Bars represent means of three independent experiments and 
their respective standard deviations. (C) Dose-response effect of transition metals on the viability of H9c2 cells. 
Cells were treated with transition metals at the stated concentration for 48 h before viability was determined. 
Indicator points represent means of three independent experiments and their respective standard deviations. 
Values are mean ± SD (n = 3 experiments at least for each treatment).
www.nature.com/scientificreports/










15 µM 11.4 nM 30 µM
7.5 µM 5.7 nM 15 µM
3.75 µM 2.8 nM 7.5 µM
Cu
0.3 mM 2.79 µM 2 mM
0.08 mM 123 nM 1 mM
Co
0.75 mM 319 µM 0.5 mM
0.4 mM 170 µM 0.25 mM
Table 3. Correction to metal nominal concentration in DMEM. *Free ions calculated with VMINTEQ 
software.
Figure 8. Cytotoxicity of Individual Transition Metals on HaCat cells. Effect of transition metals on the viability 
of HaCat cells. Cells were treated with individual treatments of transition metals at different concentrations for 
24 h and viability was determined. Data are expressed as percent of control mean ± SEM and analyzed by one-
way ANOVA, with a Tukey post hoc test. **p < 0.01 vs. control; N = 3.
Figure 9. Cytotoxicity of STMCs on HaCat cells. Effect of STMCs on the viability of HaCat cells. Cells were 
treated with STMCs at different concentrations for 24 h and viability was determined. Data are expressed as 
percent of control mean ± SEM and analyzed by one-way ANOVA, with a Tukey post hoc test. **p < 0.01 vs. 
control; N = 3.
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13Scientific RepoRts | 7: 903  | DOI:10.1038/s41598-017-01017-7
other hand, B16F10 and HaCaT cells are skin melanoma and keratinocytes respectively. These cells are more 
resistant to different conditions as they have mutations in genes that control cell cycle, DNA repair, and apoptosis 
pathways72.
The MIC values obtained for each metal on both Gram-negative and Gram-positive microorganisms and the 
IC50s obtained in this work, although promising for the development of future therapeutics, cannot be directly 
compared to their reported LD50 values, as our work was made in vitro while LD50s are calculated from in vivo 
experiments. Even though these in vitro studies set the basis for pharmacological applications, as it has been 
shown in several reports73, 74, both bioavailability and biodistribution of the transition metals used here need to 
be obtained in animal models in order to determine their safety.
Although these concentrations were found to be higher than reported as cytotoxic in human cells and harmful 
in humans cases by oral administration, an additional important application of these treatments can be found 
in topical treatment, as seen in Table 2. Skin and soft tissue infections have a great incidence in communities 
and hospitals75, 76 and about 30% of diabetic patients have cutaneous disorders77. These kind of infections, like 
cellulitis, abscesses, diabetic foot infections and surgical site infections caused by multidrug-resistant pathogens, 
recently have become more common and alternatives to the current treatments are needed78–80. Therefore, here 
we open an area of opportunity for the use of transition metals in dermal treatments. The use of copper as a 
potential therapeutic in dermal wound healing was reported by Sen et al.81 noting copper sensitive pathways that 
regulate wound healing mediators. Some other authors reported the use of transition metals, especially silver, 
as antimicrobial agents in wound dressing materials and regeneration materials82–84. The STMCs reported here 
can be considered as potential antimicrobial agents in the manufacture of these kind of materials, since we show 
STMCs to be capable of inhibiting bacterial growth at lower concentrations than each metal as a separate treat-
ment. Furthermore, as shown in this work, the use of STMCs has the advantage of achieving a synergistic effect, 
allowing the use of lower transition metal doses, and delaying the emergence of resistance to either85. Thus, these 
Figure 10. Cytotoxicity effects of Ag and transition metals at concentrations adjusted for speciation on 
melanocytes and myoblast cells. Effect of transition metals, alone or in combination, with Ag on the viability of 
(A) B16F10 and (B) H9c2 cells. Cells were treated with each transition metal (in nominal µM: Cu 80; Co 400; 
Zn 31.2) alone or in the combination with Ag (15 µM), for 24 h. Values are mean ± SD. *p < 0.05 vs. Control; (a) 
vs. Ag. (n = 3 experiments at least for each treatment).
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combinations could be used as a platform to develop novel combinatorial treatments against antibiotic resistance 
strains. Due to the increments in permeability shown in this work the combinations of metals and silver have 
potential to be combined with commonly used antibiotics to re-sensitize resistant bacteria. These would allow 
the decrease in doses of both, antibiotics and transition metals, and at the same time mitigate the possibility of a 
toxic effect on human cells.
Conclusions
In correlation with the results provided in this work, we conclude that transition metals, Zn, Cd, Ni and Cu, 
are able to enhance the inhibitory and bactericidal activities of silver salts against Escherichia coli and B. subti-
lis; under the conditions implemented in this study. Nevertheless, the extent to which each STMC affected the 
behavior of Ag differed significantly. Ag/Ni STMC showed significant potentiation of bactericidal activity when 
compared to Ag in E. coli assays, however no significant effects were observed for treatments in B. subtilis. Cu, Ni, 
and Cd were able to enhance Ag inhibitory activity at 0.25 and 0.5 of their respective MICs, whereas Zn exhibited 
similar behavior only at 0.5 of its MIC. Meanwhile, Cu, Zn and Co were able to enhance Ag inhibitory activity 
at these fractions of their respective MICs in B. subtilis assays. We demonstrate that STMCs Ag-Cu, Ag-Ni and 
Ag-Zn exhibit their antimicrobial effect through an increase in cell permeability. The findings described herein 
provide significant advances in understanding the interactions and effects of combined transition metals and set 
the basics for future design of metallo-pharmaceutical treatments. In addition, most STMCs tested in this work 
exhibit antibacterial effects at non-toxic concentrations for human keratinocyte cells. Based on this data, we can 
conclude that dermic therapeutic applications could be possible, although further investigation need to be taken 
regarding non-cytotoxic concentrations. Taken together, our results suggest that due to the inherent complexity 
related to the synergistic effects observed in the systems studied, this work provides a platform for further inves-
tigations focused on unveiling deeper correlations to support the use of metallo-pharmaceuticals in future design 
of therapeutic strategies.
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